Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-056093

Chief Scientific Officer sold 63,606 shares at an average $28.25 ($1,796,676)

  • Chief Scientific Officer acquired 55,606 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-06 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $4.30 $215,000 187,582 D
2024-05-06 Sale : show line 2 in the form 10b5-1 −37,723 $27.82 $1,049,454 149,859 D
2024-05-06 Sale : show line 3 in the form 10b5-1 −20,277 $28.54 $578,706 129,582 D
2024-05-07 Exercise or conversion : show line 4 in the form 10b5-1 +5,606 $4.30 $24,106 135,188 D
2024-05-07 Sale : show line 5 in the form 10b5-1 −5,606 $30.06 $168,516 129,582 D
Open-market sales · 63,606 sh · avg $28.25 · $1,796,676

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-05-06 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −50,000 138,593 D
2024-05-07 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −5,606 132,987 D
Loading xslF345X05/ownership.xml…